User:Allie Pointer/Pointer Sandbox 1

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
-
==Interleukin-12 Background==
+
==Interleukin-12==
<StructureSection load='1stp' size='340' side='right' caption='Caption for this structure' scene=''>
<StructureSection load='1stp' size='340' side='right' caption='Caption for this structure' scene=''>
This is a default text for your page '''Allie Pointer/Pointer Sandbox 1'''. Click above on '''edit this page''' to modify. Be careful with the &lt; and &gt; signs.
This is a default text for your page '''Allie Pointer/Pointer Sandbox 1'''. Click above on '''edit this page''' to modify. Be careful with the &lt; and &gt; signs.
Line 5: Line 5:
You may include any references to papers as in: the use of JSmol in Proteopedia <ref>DOI 10.1002/ijch.201300024</ref> or to the article describing Jmol <ref>PMID:21638687</ref> to the rescue.
You may include any references to papers as in: the use of JSmol in Proteopedia <ref>DOI 10.1002/ijch.201300024</ref> or to the article describing Jmol <ref>PMID:21638687</ref> to the rescue.
-
Interleukin-12 also known as IL-12. Different cells including macrophages, some B cells, and neutrophils produce IL-12 to generate immunity to pathogens. It can also stimulate the proliferation of natural killer cells, which kills cells in someone’s body that has been affected by a pathogen, and T cells. IL-12 is also a heterodimeric glycoprotein. In IL-12 there are two subunits that are di-sulfide linked. That di-sulfide bonds in not necessary for the formation of IL-12. It is also not necessary for the secretion of IL-12, but the di-sulfide bonds help to stabilize the subunits. There have been studies done to see its affects for immunotherapy
 
-
== Notes for making page ==
+
== Background ==
Try to figure out how to get image to show up first thing when opening page
Try to figure out how to get image to show up first thing when opening page
Line 18: Line 17:
Reference shows up have to be above the (arrow references arrow)
Reference shows up have to be above the (arrow references arrow)
 +
 +
Interleukin-12 also known as <scene name='83/837863/Il-12/7'>il-12</scene>. There are different cells including macrophages, some B cells, and neutrophils that produce IL-12 to generate immunity to pathogens. It can also stimulate the proliferation of natural killer cells, which kills cells in someone’s body that has been affected by a pathogen, and T cells. IL-12 is also a heterodimeric glycoprotein. In IL-12 there are two subunits that are di-sulfide linked. That di-sulfide bonds in not necessary for the formation of IL-12. It is also not necessary for the secretion of IL-12, but the di-sulfide bonds help to stabilize the subunits. There have been studies done to see its affects for immunotherapy
 +
== What it is ==
== What it is ==
-
Il-12 is a cytokine. A cytokine is small protein that signals the immune responses between lymphocytes and macrophages to generate cell mediated immunity. Cell mediated immunity is when the body fights off pathogens without the production of antibodies.
+
Il-12 is a cytokine. A cytokine is small protein that signals the immune responses between lymphocytes and macrophages to generate cell mediated immunity, in which the body fights off pathogens without the production of antibodies.
== Structural highlights ==
== Structural highlights ==
-
Il-12 is a heterodimer meaning it has two polypeptide chains that differ in their composition and the polypeptide chains. Those polypeptide chains have carbohydrates attached meaning that il-12 is also a glycoprotein. It has two disulfide linked subunits p35 and p40 (1F42). The p35 subunit is similar in structure to other class 1 cytokines. The p40 subunit is similar to hematopoietic cytokines. Hematopoietic cytokines make hematopoietic cells turn into different blood cells. P35 is unstable without p40 but p40 is not unstable without p35. P35 has a long chain four helix bundle that binds to a soluble alpha chain receptor subunit which is p40. There is an arginine residue (I didn’t know if there was a way to highlight the arginine residue in the pocket) that projects from the p35 into a pocket in p40. That pocket could be a spot for an inhibitor to bind so Il-12 cannot form. When p35 and p40 combine they form il-12 though which is also known as p70. When looking at the disulfide bond between p35 and p40 they found the it is not necessary for il-12 to form and secrete but it makes sure there is stabilization between these subunits. P35 is unstable so when stabilized with p40 it can be secreted.
+
Il-12 is a heterodimer, meaning it has two polypeptide chains that differ in their composition and number of amino acids. Those polypeptide chains have carbohydrates attached meaning that il-12 is also a glycoprotein. It has two disulfide linked subunits p35 and '''p40 (1F42)'''. <ref>DOI10.1093/emboj/19.14.3530</ref> The p35 subunit is similar in structure to other class 1 cytokines. The p40 subunit is similar to hematopoietic cytokines. Hematopoietic cytokines make hematopoietic cells turn into different blood cells. P35 is unstable without p40 and can not be secreted but p40 can function without p35. <ref>DOI10.1093/emboj/19.14.3530</ref> P35 has a long chain four helix bundle that binds to a soluble alpha chain receptor subunit which is p40.<ref>DOI10.1093/emboj/19.14.3530</ref> There is an '''arginine residue (I didn’t know if there was a way to highlight the arginine residue in the pocket)''' that projects from the p35 into a pocket in p40. That pocket could be a spot for an inhibitor to bind so Il-12 cannot form. When p35 and p40 combine they form il-12 which is also known as p70. When looking at the disulfide bond between p35 and p40 they found the it is not necessary to form and secrete il-12 but it makes sure there is stabilization between these subunits. <ref>DOI10.1093/emboj/19.14.3530</ref>
== Function ==
== Function ==
Line 55: Line 57:
== References ==
== References ==
<references/>
<references/>
-
<ref name=il-12>PMID: 24514955</ref>
 
-
<ref name=heterodimeric>PMID: 10899108</ref>
 
-
<ref>DOI: 10.2174/187152809787582507</ref>
 

Revision as of 23:48, 28 April 2020

Interleukin-12

Caption for this structure

Drag the structure with the mouse to rotate

References

  1. Hanson, R. M., Prilusky, J., Renjian, Z., Nakane, T. and Sussman, J. L. (2013), JSmol and the Next-Generation Web-Based Representation of 3D Molecular Structure as Applied to Proteopedia. Isr. J. Chem., 53:207-216. doi:http://dx.doi.org/10.1002/ijch.201300024
  2. Herraez A. Biomolecules in the computer: Jmol to the rescue. Biochem Mol Biol Educ. 2006 Jul;34(4):255-61. doi: 10.1002/bmb.2006.494034042644. PMID:21638687 doi:10.1002/bmb.2006.494034042644
  3. Lasek W, Zagozdzon R, Jakobisiak M. Interleukin 12: still a promising candidate for tumor immunotherapy? Cancer Immunol Immunother. 2014 May;63(5):419-35. doi: 10.1007/s00262-014-1523-1., Epub 2014 Feb 11. PMID:24514955 doi:http://dx.doi.org/10.1007/s00262-014-1523-1
  4. . PMID:216315890657
  5. . PMID:216315890657
  6. . PMID:216315890657
  7. . PMID:216315890657

Proteopedia Page Contributors and Editors (what is this?)

Allie Pointer

Personal tools